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Abstract
Background: Although increased sympathetic nervous system (SNS) activity is commonly associated with major depressive disorder (MDD) and cardiovascular disease (CVD), a biomarker linking these two entities remains elusive. We therefore evaluated the relationship between depressive symptoms and cardiovascular modulation via heart rate variability (HRV), brachial blood pressure (BP), ambulatory BP (ABP), and low frequency component of systolic blood pressure variability (LFSBP), a surrogate of sympathetic vasomotor tone. We hypothesized that LFSBP would be the strongest predictor of depressive symptoms compared to HRV and BP measurements.
Methods:
Eighty young healthy females (20.51±2.82years) were evaluated for depressive symptoms using the Center for Epidemiologic Studies Depression Scale (CES-D). Data collection was conducted after a 10-min resting period. Beat-to-beat blood pressures were recorded for 5-min at baseline (BASE) followed by a 3-min cold pressor test (CPT). ABP was obtained for 24 h. Results: Hierarchical multiple regression analyses indicated that LFSBP at BASE was a stronger predictor of CES-D variance than BP and HRV indices, with LFSBP uniquely accounting for 8.1% of variance in CES-D scores during laboratory beat-to-beat BP assessments and 44.7% in ABP assessments. Individuals with acute depression scores (n=12;CES-D ≥ 16) had significantly higher (p<.001) mean LFSBP values (6.66±2.54mmHg 2 ) than the remaining sample (3.32±2.2mmHg 2 ) whereas no other significant differences were detected in any of the other cardiovascular variables. Cardiovascular responses to CPT did not predict CES-D scores. Conclusion: These findings suggest that LFSBP could be a biomarker of neurovascular functioning with potential clinical implications for understanding the interaction between MDD and CVD.
INTRODUCTION
Major depressive disorder (MDD) is associated with increased cardiovascular morbidity and mortality. 1, 2 However, the mechanisms that underlie how the interaction between MDD and vascular functioning impacts cardiovascular disease (CVD) progression remain unknown.
Although dysautonomia, including increased sympathetic nervous system (SNS) activity and/or decreased vagal tone, may be a common pivotal factor between MDD and CVD, a clinical test or biomarker linking MDD and CVD remains elusive. [3] [4] [5] [6] The influence of depressive symptoms on vascular function and cardiovascular responsiveness to stress, both in laboratory and home settings, have been well established. [7] [8] [9] [10] In laboratory measurements, Seldenrijk et al. 11 reported that MDD severity is associated with lower carotid compliance. Recently, we demonstrated that higher depressive symptoms, in individuals without MDD, are associated with cardiac hyperactivity during SNS stimulation (cold pressor test, CPT) contributing to increased aortic hemodynamics. 12 Light et al. 13 showed that catecholamine concentrations were associated with exaggerated BP responses to laboratory stressors, including CPT, in females with high depressive symptoms. Similarly home based measurements, by means of ambulatory blood pressure (ABP), have shown that morning systolic blood pressure (SBP) surge and nocturnal SBP dipping are positively correlated and negatively correlated with depressive symptoms, respectively. 14,15 Furthermore, the ambulatory arterial stiffness index (AASI) may be increased in patients with MDD owing to increased arterial stiffness and potentially increased SNS activity. 16, 17 Together these studies suggest that MDD has a profound impact on the vasculature most likely to be mediated via increased SNS tone, and hence markers of neurovascular modulation may better demonstrate the association between MDD and CVD.
Power spectral analysis of heart rate variability (HRV), measured in time and/or frequency domains, has been used for evaluating cardiac autonomic regulation in patients with mood disorders and CVD. [18] [19] [20] [21] Patients with MDD have been shown to have lower HRV suggesting reduced cardiovagal modulation and increased SNS activity. [22] [23] [24] [25] Since increased sympatho-vagal tone increases cardiac risk, the association between decreased HRV and MDD seems to predispose psychiatric patients to adverse cardiac events such as myocardial infarction, arrhythmias as well as sudden cardiac arrest. 4, 23, 26 Together these studies suggest that MDD decreases cardiac parasympathetic nervous system (PNS) activity rather than affecting SNS tone, especially at the subclinical level. This may be expected due to the greater influence of vagal tone over SNS flow on heart rate modulation. 21, 27 However, vascular autonomic modulation is known to have a predominant SNS tone, [28] [29] [30] and hence the evaluation of the rhythmical oscillations in systolic blood pressure in the low frequency domain (LFSBP), a surrogate of sympathetic vasomotor tone, 31 may be more appropriate for understanding the influence of SNS hyperactivity on vascular function in MDD. Although several studies have shown a robust association between vascular dysfunction and MDD, the association between LFSBP and depressive symptoms has not been explored.
As MDD is known to result in SNS hyperactivity and impaired vascular functioning, it is reasonable to explore LFSBP as a potential biomarker of cardiovascular functioning in healthy individuals that vary in depressive symptoms. Since females have higher prevalence rates of MDD than males 2 , the present study evaluated sympathetic vasomotor tone at rest and during SNS stimulation in healthy young females. We tested the hypothesis that LFSBP would be a stronger predictor of depressive symptoms than laboratory brachial BP, time and frequency domain measures of HRV, and ABP.
METHODS

STUDY SUBJECTS
Eighty apparently healthy young adult female undergraduates (19-31 years of age) participated in this study. Participants were excluded from the study if they had hypertension (BP ≥140/90 mmHg), chronic diseases and/or were taking medications (e.g., beta blockers, antidepressants, and stimulants) that could affect the cardiovascular variables. Participants were asked to abstain from caffeine, alcohol, and strenuous physical activity for at least 24 hours prior to testing.
Participants were tested in the early follicular phase of the menstrual cycle in order to avoid potential variations in pressure wave morphology and cardiac reactivity. All participants were recruited from a university sample and gave their written consent prior to the experiments as approved by The Florida State University Institutional Review Board.
STUDY DESIGN AND EXPERIMENTAL PROTOCOL
Participants were first introduced to the study procedures and familiarized with the laboratory setting. Height, weight, waist, arm circumference, as well as finger circumference were then measured and participants filled out a health questionnaire indicating their physical health history and depressive symptomatology.
Data collection was conducted in the morning after at least a 10 hour postprandial period at the same time of the day (± 2 hours) in order to minimize potential diurnal variations in vascular reactivity. In order to test cardiac reactivity, we used the cold pressor test (CPT) as a stressor since it evokes SNS stimulation, increases hemodynamics, and increases LFSBP. [32] [33] [34] Participants were seated, and then given a 10 minute rest period in a quiet, dimmed light, and temperature controlled room (23 ± 1º C). Within 5 minutes after the rest period, brachial BP was measured and used to calibrate beat-by-beat finger BP waveforms in order to obtain hemodynamic variables during a 5 minute baseline (BASE) period. Immediately following the BASE measurements, participants completed the CPT by submerging their hand in cold water (4ºC) for 3 minutes. During the CPT a researcher made sure the participant kept their hand in the water, to wrist level, throughout the entire task. Beat-by-beat BP was continuously obtained for 8 minutes (5minutes BASE and 3 minutes CPT). We did not control breathing frequency (12) (13) (14) rsp/min) throughout the test since it has been shown to be similar to spontaneous breathing in healthy volunteers 35 for HRV and LFSBP determinations. In addition, controlling breathing frequency may impose an additional stress to the participants. 
DEPRESSION SCALE
Depression was measured the same day the participant came into the lab using the 10-item Center for Epidemiologic Studies Depression Scale (CES-D). 37, 38 The CES-D has been widely used as a stable measure of chronic depressive symptoms. 39, 40 Responses were summed into one overall score, with a possible range of 0 to 30. Prior studies involving the longer 20-item version of this scale have used a rough estimate of the top quintile of scores to define participants as "depressed," and a validation study found that a score of 16 or higher has 99% sensitivity to identifying acute depression. 39, 40 CARDIOVASCULAR MEASUREMENTS Beat-by-beat blood pressure
Brachial SBP was used to calibrate beat-by-beat blood pressure which was recorded for an 8-minute epoch via finger plethysmography (NIBP-100 Biopac Inc., Goleta, CA, USA). This method is validated and has been shown to provide accurate measurement of BP changes when compared with intra-arterial blood pressure. 41 Heart rate variability
The BP peaks were used to calculate the time duration of intervals between heartbeats (RRI) and were automatically detected using commercially available software (WinCPRS, Turku, Finland).
The RRI were inspected for artifacts, premature beats and ectopic episodes in order to calculate HRV parameters. The HRV was calculated through the time domain statistics percentage of adjacent R-R intervals that differ by 50 ms (pNN50), root mean square of successive R-R differences (RMSSD), and total power (TP) or variance in RRI. These are considered markers of cardiac vagal modulation 19 and the TP of HRV is an estimation of the global activity of the autonomic nervous system. 29 The main spectral components of the HRV that we calculated, by means of Fast Fourier transformation, were the low frequency (LF; 0.04-.15Hz) and the high frequency (HF; 0.15-0.4Hz). HF is a marker of cardiac PNS activity. 29 The LF component of HRV is mediated by both SNS and PNS activities 19 and may also represents baroreflex function. 42 Alternatively, the use of absolute units (ms 2 ) for HF and LF may be obtained in proportion to the TP which is expressed in normalized units (nu). Normalization is used to exclude the influence of other fractal components and to control for the changes in TP hence it is more appropriate to report LF and HF responses to stress in nu. 19 Blood pressure variability
The SBP time series was resampled at 5 Hz and the continuous data stream passed through a low pass impulse response filter with a cutoff frequency of 0.5 Hz. The data were then subjected to Fast Fourier transform algorithms using a Hanning spectral window and subsequently smoothed using a triangular averaging function to produce a spectrum. The power was calculated by measuring the area under the peak of the power spectra density curve. Power spectra within the 0.04-0.15 Hz range were defined as LFSBP and taken as an estimate of sympathetic vasomotor modulation. 31 In our laboratory, the intraclass correlation coefficients for resting SBP, DBP, were obtained using the SpaceLabs analysis software. AASI was defined as one minus the regression slope. The stiffer the arterial tree, the closer the regression slope and AASI are to zero and one, respectively. and was the only significant predictor in the full model (see Table 2 ). Table 4 ).
CPT Difference Score Analyses. Paired sample t-tests comparing CPT to BASE changes indicated all cardiovascular variables, except LFSBP, significantly changed in the expected directions with increases in SBP, DBP, HR, LnTP, LnpNN50, LnRMSSD, nLF and a decrease in nHF (see Table 3 ). HMR results of difference scores showed none of the models accounted for a Table 2 ).
Ambulatory Blood Pressure Analyses. Fifty eight females completed the ABP measurements.
Those who did not complete this measurement had similar baseline characteristics than those with the complete high quality measurements as compared by means of Student's t-tests (Table   4 (Table 3) .
DISCUSSION
The aim of the present study was to evaluate sympathetic vasomotor tone as a potential Recently, the use of biomarkers for diagnosing and evaluating therapeutic effectiveness in patients with MDD has been explored. Some studies have suggested novel serum biomarkers for detecting individuals at increased risk of MDD in addition to noninvasive measures for evaluating psychological status. [44] [45] [46] [47] Nevertheless, an easily obtained noninvasive biomarker which may be indicative of cardiovascular alterations in healthy and MDD patients remains elusive. Previous research, using laboratory and/or home based cardiovascular measurements, has shown that depressive symptoms contribute to cardiovascular functioning impairments in addition to increased CVD risk in both healthy and clinical populations. 1, 6, 12, 25, 48 In home based ABP measurements, prior studies have shown associations between depressive symptoms and nocturnal SBP 14 . Here we did not find associations between ABP, AASI and depressive symptoms suggesting a potential limitation of ABP for detecting CVD risk in healthy young females with higher depressive symptoms. In laboratory measurements, during SNS stimulation, we and others have shown an association between depressive symptoms and increased brachial BP, aortic BP, as well as blood catecholamine concentration. 12, 13, 49, 50 In addition, Gordon et al. 51 and Solomon et al. 52 documented that after SNS stimulation depressive symptoms were associated with attenuated heart rate recovery or impaired cardiovagal reactivation. In the present study we observed that LFSBP was the strongest predictor of depressive symptoms at Although it is unclear how depressive symptoms evoke SNS hyperactivity and attenuated PNS activity, dysautonomia seems to be a common pathway, and it may represent a common manifestation in the development of MDD and CVD. 18, [55] [56] [57] Moreover, MDD is commonly associated with dysautonomia, reflected as increased sympathovagal tone, which may be a pivotal process in the development of cardiovascular complications such as arrhythmias, hypertension, arterial stiffening, and atherosclerosis. 4, 11 Currently, the impact of depressive symptoms and LFSBP on vascular function is not well understood. However, increased vasomotor tone may lead to vascular dysfunction and endothelial damage which are pivotal factors in the development of CVD. [58] [59] [60] Chen et al. 61 demonstrated that, in healthy subjects without significant CVD, high depressive scores were associated with impaired brachial flow, medicated vasodilation and depletion of circulating endothelial progenitor cells suggesting endothelial dysfunction and remodeling. It could be that the associated depressive state with SNS hyperactivity may promote an atherosclerotic environment and inflammation affecting the endothelial cells. Since we observed that high depressive symptoms are associated with increased LFSBP, our main finding adds to the notion that MDD may evoke endothelial dysfunction and damage as a result of the complex interaction between SNS activity and nitric oxide production. 61, 62 Together the results of previous studies and our data suggest that increased sympathetic vasomotor tone may be a pivotal physiological alteration associated with depressive symptoms and may ultimately promote cardiovascular damaging and subclinical CVD.
Potential limitations of this study include a limited sample size; only female participants were included, lack of autonomic function serum markers including catecholamines and cortisol, as well as 24 hour HRV. In addition, cardiovascular responses during the recovery period after SNS stimulation were not evaluated. In this study we did not evaluate aortic PWV, a gold standard measure for arterial stiffness and a strong cardiovascular risk factor, or direct measures of SNS such as muscle SNS activity. We did not measure sleep quality in this study, which may influence autonomic function. However, the selected scale of CES-D has questions regarding sleep quality. Our statistical model did not control for anxiety and/or physical activity. Finally, our sample comprised young adult females who were not clinically diagnosed as suffering from We thank Mr. Preston C. Brown for his assistance in subject recruitment and data acquisition.
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